Oxethazaine
Oxethazaine is a topical anesthetic, in preventing acid-induced esophageal pain. (In Vivo) :Oxetacaine (intraperitoneal injection; 5, 10, and 15 mg/kg; during days 4–11) doses induces significant conditioned place preference (CPP), and there are no differences among the groups. While its postive control group phentermine only 3 mg/kg causes significant CPP. .
Product Specifications
CAS Number
126-27-2
Product Name Alternative
Oxethazaine | WY 806 | Wy-806 | Oxetacaine | Emoren | FH 099
Purity
>98% (HPLC)
Solubility
Soluble in DMSO
Smiles
OCCN (CC (N (C (C) (C) CC1=CC=CC=C1) C) =O) CC (N (C (C) (C) CC2=CC=CC=C2) C) =O
Molecular Formula
C28H41N3O3
Molecular Weight
467.64
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Acetamide, 2,2'- ((2-hydroxyethyl) imino) bis (N- (1,1-dimethyl-2-phenylethyl) -N-methyl-
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF594 conjugate, 0.1mg/mL
CD10 (Membrane Metalloendopeptidase) (MME/1892), CF568 conjugate, 0.1mg/mL
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1865R), 0.2mg/mL
